Related Experiment Videos
Neoadjuvant chemotherapy for invasive bladder cancer: future directions
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Seminars in Oncology
|October 1, 1990
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.
European journal of cancer (Oxford, England : 1990)·2021
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Periprostatic adipose inflammation is associated with high-grade prostate cancer.
Prostate cancer and prostatic diseases·2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.
Clinical pharmacology and therapeutics·2017
A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
From imaging to action: MRI features direct surgical strategy in low rectal cancer.
Seminars in oncology·2026
Regulation of PD-1 and PD-L1 expression in tumor immune microenvironment.
Seminars in oncology·2026